Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A8219 Gefitinib (ZD1839)3 CitationTarget: EGFRSummary: Selective EGFR inhibitor
- A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
- A1882 Cediranib (AZD217)Target: VEGFRSummary: VEGFR inhibitor receptor,highly potent
- A1778 Vatalanib (PTK787) 2HClTarget: VEGFRSummary: Tyrosine kinase receptor inhibitor
- A8332 R788 disodiumTarget: SykSummary: Syk inhibitor,ATP competitive and potent
- A8557 TAE226 (NVP-TAE226)1 CitationTarget: FAKSummary: FAK inhibitor,potent and ATP-competitive
- B5859 EntrectinibTarget: Trk Receptors|ALK|ROS1Summary: Orally active inhibitor of ALK kinase